ZAHRANIČNÍ ÚČAST

Prof. Rupert Bartsch, MD

• Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

Prof. Daniele Generali, MD

• Department of Medical Surgery and Health Sciences, University of Trieste, 34129, Trieste, Italy

Dr Filip Janku, MD, PhD

• Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The university of Texas MD Anderson Cancer Center, USA

Prof. Gal Markel MD, PhD

• Chief Scientist, Head of the Research laboratory at the Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Izrael

Jennifer Leigh McQuade, MD, MS, MA

• Melanoma Medical Oncology, The university of Texas MD Anderson Cancer Center, USA

Prof. Dr. Manuela Schmidinger

• Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

Vivek Subbiah, MD

• Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The university of Texas MD Anderson Cancer Center, USA

Eduardo Vilar-Sanchez, MD, PhD

• Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The university of Texas MD Anderson Cancer Center, USA